Michael Cooper Pearce's Net Worth
$957 Thousand
Who is Michael Cooper Pearce?
Michael Cooper Pearce does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include ENZON PHARMACEUTICALS, INC., SPATIALIZER AUDIO LABORATORIES INC, PERNIX THERAPEUTICS HOLDINGS, INC., Myrexis, Inc., and Journey Medical Corp.
SEC CIK
Michael Cooper Pearce's CIK is 0001413616
Past Insider Trading and Trends
2012 was Michael Cooper Pearce's most active year for acquiring shares with 16 total transactions. Michael Cooper Pearce's most active month to acquire stocks was the month of October. 2012 was Michael Cooper Pearce's most active year for disposing of shares, totalling 27 transactions. Michael Cooper Pearce's most active month to dispose stocks was the month of October. 2009 saw Michael Cooper Pearce paying a total of $223,668.10 for 120,001 shares, this is the most they've acquired in one year. In 2012 Michael Cooper Pearce cashed out on 327,386 shares for a total of $1,278,138.38, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
ENZON PHARMACEUTICALS, INC. (ENZN) Snapshot price: $0.1601
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -4.62% | -77.10K |
$0.19 | -$14,337.64 | 1.59M |
Aug 24 - Aug 25
| |||
Form 4
| +31.76% | 506.29K |
$0.20 | $101,258.40 | 2.1M |
Aug 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
SPATIALIZER AUDIO LABORATORIES INC (ENVB) Snapshot price: $0.5
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
PERNIX THERAPEUTICS HOLDINGS, INC. No price found
President and CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +681.81% | 250K |
—
|
—
| 286.67K |
May 10
| |||
Form 4
|
—
|
0
|
$5.60 | -$27,840.40 | 36.67K |
Scheduled
|
Nov 27 - Nov 28
| ||
Form 4
|
—
|
0
|
$5.72 | -$105,556.30 | 36.67K |
Scheduled
|
Nov 23 - Nov 26
| ||
Form 4
|
—
|
0
|
$5.73 | -$63,221.50 | 36.67K |
Scheduled
|
Nov 20 - Nov 21
| ||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Scheduled
|
Oct 5 - Oct 9
| ||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Scheduled
|
Oct 3 - Oct 4
| ||
Form 4
|
—
|
0
|
$5.74 | -$138,327.88 | 36.67K |
Scheduled
|
Nov 16 - Nov 19
| ||
Form 4
|
—
|
0
|
$6.10 | -$4,894.40 | 36.67K |
Scheduled
|
Oct 5 - Oct 9
| ||
Form 4
|
—
|
0
|
$6.07 | -$105,105.80 | 120.47K |
Scheduled
|
Oct 3 - Oct 4
| ||
Form 4
| +37.50% | 10K |
—
|
—
| 36.67K |
Mar 22
| |||
Form 4
|
—
|
0
|
$6.15 | -$197,347.50 | 26.67K |
Scheduled
|
Jan 24
| ||
Form 4
|
—
|
0
|
$5.32 | -$91,602.00 | 26.67K |
Scheduled
|
Sep 9 - Sep 12
| ||
Form 4
| -3.38% | -933.00 |
$5.24 | -$19,720.60 | 26.67K |
Scheduled
|
Sep 7 - Sep 8
| ||
Form 4
| -14.29% | -4.60K |
$7.88 | -$36,236.48 | 27.6K |
Scheduled
|
Sep 2 - Sep 6
| ||
Form 4
| -3.01% | -1.00K |
$8.68 | -$8,680.00 | 32.2K |
Scheduled
|
Aug 31 - Sep 1
| ||
Form 4
| -5.14% | -1.80K |
$8.62 | -$15,520.00 | 33.2K |
Scheduled
|
Aug 29 - Aug 30
| ||
Form 4
| +40.00% | 10K |
—
|
—
| 35K |
Mar 11
| |||
Form 4
|
∞
| 25K |
—
|
—
| 25K |
Mar 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Myrexis, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Journey Medical Corp (DERM) Snapshot price: $4.77
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 30K |
—
|
—
| 30K |
Jul 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||